Skip to main content
. Author manuscript; available in PMC: 2010 Mar 12.
Published in final edited form as: J Med Chem. 2009 Mar 12;52(5):1358–1369. doi: 10.1021/jm8012344

Table 1.

a. Affinites (Ki) of the Benzoylbenzovesamicol Analogs, 9a-e, (+)-9e, (-)-9e, for VAChT and Sigma Receptors (σ1, σ2) Assayed in vitro

Ligands VAChTb
(Ki [nM])
σ1c
(Ki [nM])
σ2d
(Ki[nM])
VAChT: σ ratio
Log Pe
VAChT/σ1 VAChT/σ2
Vesamicolf 2.0 ± 1.0 25.8 ± 8.0 34.5 ± 2.0 25.8 34.5 1.40
Benzovesamicolg 0.055 ± 0.01 ND ND ND ND 2.44
(+)-FBTh 0.22±0.05 21.6±3.9 35.9±6.3 98 163 1.99
9a 4.30 ± 1.00 219.6 ± 17.3 320.0 ± 6.6 51 74 2.78
9b 0.25 ± 0.02 297.7 ± 18.7 592.6 ± 95.2 1188 2368 3.73
9c 1.68+0.14 ND ND ND ND 1.56
9d 0.48+0.03 ND ND ND ND 2.16
(±)9e 2.70 ± 0.40 191.1 ± 57.7 251.3 ± 39.2 71 93 2.99
(+)-9e 108 ± 15 185.97 ± 38.89 277.93 ± 26.66 1.7 2.8 2.99
(-)-9e 4.1 ± 0.6 658.60 ± 118.40 319.23 ± 36.64 160 78 2.99
a

Ki values (mean ± SEM) were determined in at least three experiments;

b

Ki VAChT is measured using Torpedo synaptic vesicles;

c

σ1binding is measured using guinea pig brain membranes;

d

σ2 binding is measured using rat liver preparations.

e

Calculated value at pH = 7.4 by ACD/I-Lab ver. 7.0 (Advanced Chemistry Development, Inc., Canada).